Inventor · disambiguated record
Julia Fonarev
Also filed as: FONAREV JULIA
8 granted patents·4 pending applications·44 citations·filing 2007–2024
83Inventor score
Files withDALES NATALIE5NAEGIS PHARMACEUTICALS INC2NOVARTIS AG2XENON PHARMACEUTICALS INC2CHOWDHURY SULTAN1
Top patents by PatentIndex Score
12 records- 0188US9481677B2Biaryl ether sulfonamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Nov 1, 2016·17 cites·17 claims
- 0286US8258160B2SCD1 inhibitors triazole and tetrazole compoundsDALES NATALIE·Filed 2007·Granted Sep 4, 2012·11 cites·17 claims
- 0385US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 0483US8063084B2Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levelsDALES NATALIE·Filed 2007·Granted Nov 22, 2011·6 cites·14 claims
- 0578US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 0664US2025011293A1Leukotriene synthesis inhibitorsNAEGIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0754US8293768B2Organic compoundsDALES NATALIE·Filed 2011·Granted Oct 23, 2012·0 cites·2 claims
- 0853US11976052B2Leukotriene synthesis inhibitorsNAEGIS PHARMACEUTICALS INC·Filed 2020·Granted May 7, 2024·0 cites·16 claims
- 0951US2014024583A1Organic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1049US2010240713A1Aromatic and heteroaromatic compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1146US8318949B2Organic compoundsCHOWDHURY SULTAN·Filed 2011·Granted Nov 27, 2012·0 cites·11 claims
- 1235US2012010135A1Spiro derivatives for the modulation of stearoyl-coa desaturaseDALES NATALIE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julia Fonarev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →